logo
Select company
Select metric
$ -0.28Operating Cash Flow per Share
VS
Market
25
Sector
63
Industry
84
History
100
$ 4.72Close
$ 1.13 - $ 5.34 52-Week Range
Ticker Information

Ticker

TSHA

Company Name

TAYSHA GENE THERAPIES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TAYSHA GENE THERAPIES INC - Operating Cash Flow per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TSHA - OCFPS Historical data
DateNet Cash Flow - OperationsOperating Cash Flow per ShareShare FactorWeighted Average Shares
6/30/2025$ -82.13M$ -0.281297.99M
3/31/2025$ -83.45M$ -0.311269.31M
12/31/2024$ -81.22M$ -0.321250.13M
9/30/2024$ -79.03M$ -0.31267.82M
6/30/2024$ -75.37M$ -0.321232.82M
3/31/2024$ -72.63M$ -0.311231.25M
12/31/2023$ -73.02M$ -0.631116.12M
9/30/2023$ -42.62M$ -0.341125.7M
6/30/2023$ -53.33M$ -0.83164.24M
3/31/2023$ -67.77M$ -1.07163.26M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TAYSHA GENE THERAPIES INC's latest trailing twelve months (TTM) OCFPS stands at $ 0.
  • Over the past 5 years, TAYSHA GENE THERAPIES INC's average OCFPS has been $ -1.48.
  • The median OCFPS for TAYSHA GENE THERAPIES INC during this period was $ -0.95
  • TAYSHA GENE THERAPIES INC reached its highest OCFPS over the past 5 years at $ -0.28.
  • The lowest OCFPS recorded by TAYSHA GENE THERAPIES INC in the same timeframe $ -3.64

TAYSHA GENE THERAPIES INC's OCFPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCFPS Benchmarks
CompanyOCFPS
RLAY : RELAY THERAPEUTICS INC $ -1.53PRAX : PRAXIS PRECISION MEDICINES INC $ -8.91LENZ : LENZ THERAPEUTICS INC $ -1.68DNTH : DIANTHUS THERAPEUTICS INC $ -2.8IMNM : IMMUNOME INC $ -2.05TNXP : TONIX PHARMACEUTICALS HOLDING CORP $ -8.85PRME : PRIME MEDICINE INC $ -0.77NUVB : NUVATION BIO INC $ -0.49PGEN : PRECIGEN INC $ -0.22ATAI : ATAI LIFE SCIENCES NV $ -0.38

Similar metrics to Shares WA:

Definition of Operating Cash Flow per Share

[Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
CF - Operations / (Shares WA * Share Factor)
(=) OCFPS OCFPS for TAYSHA GENE THERAPIES INC is calculated as follows: CF - Operations [ $ 0 ] / (Shares WA [ 11.73M ] * Share Factor [ 1 ])
(=) OCFPS [ $ 0 ]

TSHA - Operating Cash Flow per Share, Last 5 years

$ -3.64

Minimum

Jun 30, 2022

$ -0.28

Maximum

Jun 30, 2025

$ -1.48

Average

$ -0.95

Median

OCFPS Benchmark Analysis

 The chart above depicts the distribution of OCFPS for companies in the Total Stock Market. The average OCFPS of the companies is $ 1.65 with a standard deviation of $ 3.42.
The following table provides additional summary stats:
OCFPS in the Market:
filtered constituents3.79K
min$ -9.04
max$ 11.43
average$ 1.65
median$ 0.89
std$ 3.42